Insider · CIK 0001252004

EPSTEIN ROBERT S

Reports to the SEC for 5 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001252004

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+87.9K sh	—	—	87,900
2026-06-11	VCYTVERACYTE, INC.A Award	Director	AAward	+5,272 sh	—	—	57,718
2026-05-20	VCYTVERACYTE, INC.S Sale	Director	SSale	−10K sh	$44.01	−$440K	52,446
2026-05-05	FATEFATE THERAPEUTICS INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$1.69	+$42.3K	36,331
2026-05-05	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	—	—	0
2025-10-01	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.94	+$79.4K	83,919
2025-10-01	VCYTVERACYTE, INC.S Sale	Director	SSale	−21.5K sh	$35.08	−$753K	62,446
2025-10-01	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-06-18	VCYTVERACYTE, INC.A Award	Director	AAward	+9,321 sh	—	—	73,919
2025-05-29	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2025-05-21	ILMNILLUMINA, INC.A Award	Director	AAward	+3,780 sh	—	—	22,139
2025-01-06	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$8.04	+$161K	64,598
2025-01-06	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2024-11-12	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	20,000
2024-11-12	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$8.04	+$121K	59,598
2024-11-12	VCYTVERACYTE, INC.S Sale	Director	SSale	−15K sh	$38.32	−$575K	44,598
2024-06-13	VCYTVERACYTE, INC.A Award	Director	AAward	+11.5K sh	—	—	44,598
2024-06-07	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-05-16	ILMNILLUMINA, INC.A Award	Director	AAward	+2,622 sh	—	—	18,306
2024-05-15	ILMNILLUMINA, INC.F Tax Payment	Director	FTax Payment	−612 sh	$115.01	−$70.4K	15,684
2023-06-09	VCYTVERACYTE, INC.A Award	Director	AAward	+9,674 sh	—	—	33,125
2023-06-06	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-05-26	ILMNILLUMINA, INC.A Award	Director	AAward	+1,532 sh	—	—	16,296
2023-05-25	ILMNILLUMINA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,600 sh	$71.09	+$540K	14,764
2023-05-25	ILMNILLUMINA, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,600 sh	—	—	0
2023-05-24	ILMNILLUMINA, INC.F Tax Payment	Director	FTax Payment	−492 sh	$212.65	−$105K	7,164
2022-06-16	VCYTVERACYTE, INC.A Award	Director	AAward	+14.7K sh	—	—	23,451
2022-06-09	FATEFATE THERAPEUTICS INCA Award	Director	AAward	+8,650 sh	—	—	11,331
2022-06-09	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,893
2022-05-26	ILMNILLUMINA, INC.A Award	Director	AAward	+1,232 sh	—	—	7,656
2021-06-08	VCYTVERACYTE, INC.A Award	Director	AAward	+8,720 sh	—	—	8,720
2021-06-02	FATEFATE THERAPEUTICS INCA Award	Director	AAward	+2,681 sh	—	—	2,681
2021-06-02	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+4,334 sh	—	—	4,334
2021-05-26	ILMNILLUMINA, INC.A Award	Director	AAward	+881 sh	—	—	6,424
2021-05-25	ILMNILLUMINA, INC.F Tax Payment	Director	FTax Payment	−385 sh	$397.09	−$153K	5,543
2020-07-13	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.28	+$52.8K	10,000
2020-07-13	VCYTVERACYTE, INC.S Sale	Director	SSale	−5,583 sh	$29.92	−$167K	1,854
2020-07-13	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,854 sh	$30.51	−$56.6K	0
2020-07-13	VCYTVERACYTE, INC.S Sale	Director	SSale	−2,563 sh	$28.74	−$73.7K	7,437
2020-07-13	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2020-06-08	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-05-27	ILMNILLUMINA, INC.A Award	Director	AAward	+963 sh	—	—	4,928
2020-05-01	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-06-12	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-05-29	ILMNILLUMINA, INC.A Award	Director	AAward	+1,298 sh	—	—	3,965
2019-05-23	ILMNILLUMINA, INC.F Tax Payment	Director	FTax Payment	−589 sh	$308.97	−$182K	2,667
2019-05-03	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-05-01	ILMNILLUMINA, INC.S Sale	Director	SSale	−2,228 sh	$310.29	−$691K	4,828
2019-05-01	ILMNILLUMINA, INC.S Sale	Director	SSale	−1,200 sh	$309.51	−$371K	7,056
2019-05-01	ILMNILLUMINA, INC.S Sale	Director	SSale	−1,372 sh	$311.23	−$427K	3,456

Recent filings

Accepted (ET)
Jun 154
EPSTEIN ROBERT S0001252004-26-000004
SEC(opens sec.gov)
Jun 154
EPSTEIN ROBERT S0001193125-26-271083
SEC(opens sec.gov)
May 224
EPSTEIN ROBERT S0001252004-26-000002
SEC(opens sec.gov)
May 64
EPSTEIN ROBERT S0001193125-26-208899
SEC(opens sec.gov)
Oct 34
EPSTEIN ROBERT S0001252004-25-000005
SEC(opens sec.gov)
Jun 234
EPSTEIN ROBERT S0001384101-25-000096
SEC(opens sec.gov)
May 304
EPSTEIN ROBERT S0000950170-25-079712
SEC(opens sec.gov)
May 234
EPSTEIN ROBERT S0001127602-25-015513
SEC(opens sec.gov)
Jan 84
EPSTEIN ROBERT S0001384101-25-000004
SEC(opens sec.gov)
Nov 144
EPSTEIN ROBERT S0001384101-24-000165
SEC(opens sec.gov)
Jun 174
EPSTEIN ROBERT S0001384101-24-000101
SEC(opens sec.gov)
Jun 114
EPSTEIN ROBERT S0000950170-24-071945
SEC(opens sec.gov)
May 174
EPSTEIN ROBERT S0001127602-24-015931
SEC(opens sec.gov)

Companies

Address

6000 SHORELINE COURT SUITE 300

SOUTH SAN FRANCISCO, CA, 94080